Search research articles
Contact Us
Filters
Showing results (341-350 of 583) with videos related to
Page
of 59
Sort By:
Leukemia & Lymphoma
|
February 20, 2016
Clinical impact of ABL1 kinase domain mutations and IKZF1 deletion in adults under age 60 with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL): molecular analysis of CALGB (Alliance) 10001 and 9665
Rebecca DeBoer, Gregory Koval, Flora Mulkey, et al.
British Journal of Haematology
|
June 20, 1998
Clinical characteristics of patients with de novo acute myeloid leukaemia and isolated trisomy 11: a Cancer and Leukemia Group B study
K Heinonen, K Mrózek, D Lawrence, et al.
Genes, Chromosomes & Cancer
|
January 13, 2005
Acute myeloid leukemia with deletion 9q within a noncomplex karyotype is associated with CEBPA loss-of-function mutations
Stefan Fröhling, Richard F Schlenk, Jürgen Krauter, et al.
Blood
|
March 15, 1994
Prognostic importance of mutations in the ras proto-oncogenes in de novo acute myeloid leukemia
A Neubauer, R K Dodge, S L George, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1990
Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia
B D Cheson, P A Cassileth, D R Head, et al.
Lancet (London, England)
|
February 21, 2004
Prognostic importance of TLX1 (HOX11) oncogene expression in adults with T-cell acute lymphoblastic leukaemia
Adolfo A Ferrando, Donna S Neuberg, Richard K Dodge, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 19, 2000
Identification of a gene at 11q23 encoding a guanine nucleotide exchange factor: evidence for its fusion with MLL in acute myeloid leukemia
P J Kourlas, M P Strout, B Becknell, et al.
Cancer Treatment Reports
|
April 1, 1982
Chemotherapy and combined modality therapy for Hodgkin's disease: a progress report on Cancer and Leukemia Group B studies
C D Bloomfield, T F Pajak, A S Glicksman, et al.
Blood
|
March 6, 2014
Implications of the miR-10 family in chemotherapy response of NPM1-mutated AML
Violaine Havelange, Parvathi Ranganathan, Susan Geyer, et al.
Investigational New Drugs
|
May 24, 2013
A phase II study of the oral VEGF receptor tyrosine kinase inhibitor vatalanib (PTK787/ZK222584) in myelodysplastic syndrome: Cancer and Leukemia Group B study 10105 (Alliance)
Pankaj Gupta, Flora Mulkey, Robert P Hasserjian, et al.
Page
of 59
Search research articles
Search
Showing results (341-350 of 583) with videos related to
Sort By:
Page
of 59
Leukemia & Lymphoma
|
February 20, 2016
Clinical impact of ABL1 kinase domain mutations and IKZF1 deletion in adults under age 60 with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL): molecular analysis of CALGB (Alliance) 10001 and 9665
Rebecca DeBoer, Gregory Koval, Flora Mulkey, et al.
British Journal of Haematology
|
June 20, 1998
Clinical characteristics of patients with de novo acute myeloid leukaemia and isolated trisomy 11: a Cancer and Leukemia Group B study
K Heinonen, K Mrózek, D Lawrence, et al.
Genes, Chromosomes & Cancer
|
January 13, 2005
Acute myeloid leukemia with deletion 9q within a noncomplex karyotype is associated with CEBPA loss-of-function mutations
Stefan Fröhling, Richard F Schlenk, Jürgen Krauter, et al.
Blood
|
March 15, 1994
Prognostic importance of mutations in the ras proto-oncogenes in de novo acute myeloid leukemia
A Neubauer, R K Dodge, S L George, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1990
Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia
B D Cheson, P A Cassileth, D R Head, et al.
Lancet (London, England)
|
February 21, 2004
Prognostic importance of TLX1 (HOX11) oncogene expression in adults with T-cell acute lymphoblastic leukaemia
Adolfo A Ferrando, Donna S Neuberg, Richard K Dodge, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 19, 2000
Identification of a gene at 11q23 encoding a guanine nucleotide exchange factor: evidence for its fusion with MLL in acute myeloid leukemia
P J Kourlas, M P Strout, B Becknell, et al.
Cancer Treatment Reports
|
April 1, 1982
Chemotherapy and combined modality therapy for Hodgkin's disease: a progress report on Cancer and Leukemia Group B studies
C D Bloomfield, T F Pajak, A S Glicksman, et al.
Blood
|
March 6, 2014
Implications of the miR-10 family in chemotherapy response of NPM1-mutated AML
Violaine Havelange, Parvathi Ranganathan, Susan Geyer, et al.
Investigational New Drugs
|
May 24, 2013
A phase II study of the oral VEGF receptor tyrosine kinase inhibitor vatalanib (PTK787/ZK222584) in myelodysplastic syndrome: Cancer and Leukemia Group B study 10105 (Alliance)
Pankaj Gupta, Flora Mulkey, Robert P Hasserjian, et al.
Page
of 59